Special Issues
Table of Content

Non-Radical Treatment for Prostate Cancer: A New Approach

Submission Deadline: 30 April 2026 View: 285 Submit to Special Issue

Guest Editors

Prof. Dr. Tiago Rodrigues

Email: tiagorodrigues@gupuro.pt

Affiliation: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto 1649-003, Lisbon, Portugal

Homepage:

Research Interests: Uro-oncology, robotic surgery, non-radical prostate cancer treatment, micro-ultrasound, HIFU, BPH

图片1.png


Prof. Dr. James S. Wysock

Email: james.wysock@nyulangone.org

Affiliation: Department of Urology, NYU Grossman School of Medicine, New York, NY, USA

Homepage:

Research Interests: urologic oncology, cancers of the kidneys, ureters, bladder, prostate, and testes, MRI-US fusion biopsy

图片2.png


Summary

The management of localized prostate cancer is transitioning toward non‑radical, organ‑preserving treatments, driven by advances in precision diagnostics and minimally invasive technologies. While prostatectomy and radiotherapy remain standard, their risk of urinary and sexual dysfunction has spurred interest in focal therapies that aim to maintain oncologic efficacy and improve quality of life.
This Special Issue highlights these emerging approaches—including HIFU, cryoablation, laser ablation, micro‑ultrasound, and robotic guidance—and covers key areas such as patient selection, imaging-guided therapy, post-treatment follow-up, and patient-centered outcomes. We invite original research, clinical studies, technical notes, and expert reviews that provide robust, multicenter, and international insights.
Our goal is to compile an authoritative reference guiding the safe, effective, and personalized implementation of non‑radical treatment in routine urologic practice, laying groundwork for future consensus and guideline development.


Suggested Themes
· Patient selection & risk stratification beyond ISUP (e.g., tumor volume, genomics)
· Prostate imaging & biopsy innovations (mpMRI, micro-ultrasound, PRIMUS)
· Robotic & non‑invasive focal therapies (HIFU, cryoablation, laser ablation)
· Follow‑up protocols & imaging surveillance strategies
· Outcome measures & patient‑reported quality of life
· International, multicenter, real-world case series
· Technical performance & learning curve of new focal platforms


We invite contributions spanning original research, clinical studies, systematic and narrative reviews, expert commentaries, and technical developments that illuminate the evolving role of non-radical therapy in achieving oncologic control while preserving quality of life in prostate cancer management.


Keywords

Non-radical treatment, prostate cancer, robotic HIFU, minimally invasive therapy, patient-centered care, imaging,

Published Papers


  • Open Access

    ARTICLE

    Pathologic failure and salvage approaches following focal therapy for localized prostate cancer

    Samuel Tremblay, Seyed Sajjad Tabei, Shima Tayebi, Benjamin H. Hinrichs, Alon Lazarovich, Jason Koehler, Wei-Wen Hsu, Sadhna Verma, Abhinav Sidana
    Canadian Journal of Urology, DOI:10.32604/cju.2026.075779
    (This article belongs to the Special Issue: Non-Radical Treatment for Prostate Cancer: A New Approach)
    Abstract Background: Focal therapy (FT) is an emerging treatment modality for localized prostate cancer. However, limited data are available regarding the patterns of oncologic failure post-FT. This study aims to characterize the features of oncologic failure and salvage strategies following FT. Methods: Patients presenting with pathologic failure (PF) after receiving FT (cryotherapy, High-intensity focused ultrasound, or irreversible electroporation) for intermediate-risk prostate cancer were selected from a prospective registry between 2018 and 2023. All patients underwent protocol-based follow-up, including PSA testing, multiparametric MRI, and mandatory biopsy. The primary outcome was PF, defined as biopsy-confirmed Grade Group ≥2… More >

Share Link